WFG Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$12K Sell
150
-1,100
-88% -$78K ﹤0.01% 1096
2017
Q1
$87K Sell
1,250
-300
-19% -$20.1K 0.02% 514
2016
Q4
$92K Sell
1,550
-495
-24% -$30.6K 0.02% 545
2016
Q3
$136K Buy
2,045
+1,820
+809% +$113K 0.03% 453
2016
Q2
$12K Hold
225
﹤0.01% 1053
2016
Q1
$12K Sell
225
-747
-77% -$38.8K ﹤0.01% 1017
2015
Q4
$68K Sell
972
-920
-49% -$62.7K 0.02% 572
2015
Q3
$118K Buy
1,892
+14
+0.7% +$1.1K 0.04% 420
2015
Q2
$158K Buy
1,878
+933
+99% +$72.6K 0.04% 406
2015
Q1
$71K Sell
945
-1,485
-61% -$104K 0.02% 638
2014
Q4
$151K Sell
2,430
-3,108
-56% -$177K 0.03% 519
2014
Q3
$288K Sell
5,538
-1,896
-26% -$96.7K 0.05% 363
2014
Q2
$382K Sell
7,434
-3
-0% -$135 0.07% 313
2014
Q1
$353K Buy
7,437
+3,201
+76% +$164K 0.07% 317
2013
Q4
$184K Buy
4,236
+630
+17% +$26.1K 0.03% 542
2013
Q3
$155K Hold
3,606
0.02% 566
2013
Q2
$125K Buy
+3,606
New +$127K 0.02% 587

Other funds holding XBI